Stay updated on Azacitidine and Pembrolizumab in MDS Clinical Trial
Sign up to get notified when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.

Latest updates to the Azacitidine and Pembrolizumab in MDS Clinical Trial page
- Check7 days agoChange DetectedA new page revision tag Revision: v3.6.4 appears, replacing Revision: v3.6.3, indicating a small update to the page's version.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedA new page revision tag v3.6.3 was added, indicating a small update to the page version. This reflects a minor backend/content update rather than a substantive change to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedThe revision label on the page was updated from v3.6.0 to v3.6.2. This indicates a newer version without altering substantive content.SummaryDifference0.1%

- Check50 days agoChange DetectedUI labels and navigation elements have been updated on the study details page, including new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and the 'Intervention/Treatment' heading with an updated revision footnote. Additionally, new metadata labels 'Last verified' and 'Last known status was' were added.SummaryDifference2%

- Check57 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 on the page, indicating a minor version update. This change does not alter the study content or details.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page now displays Revision: v3.5.4, indicating an updated version of the page content and replacing the previous Revision: v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Azacitidine and Pembrolizumab in MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine and Pembrolizumab in MDS Clinical Trial page.